CytoMed Therapeutics Ltd
GDTC1.865USD
+0.035+1.91%
Market hours （ET）Quotes delayed by 15 min
USD0.000Pre-market (ET)
21.50MMarket Cap
--P/E TTM
CytoMed Therapeutics Ltd
1.865
+0.035+1.91%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2024H2
FY2024H1
FY2023H2
FY2023H1
FY2022H2
FY2022H1
FY2021H2
FY2021H1
FY2020H2
FY2020H1
Operating cash flows (indirect method)
Cash flow from continuing operating activities
-11.35%-1.56M
43.81%-1.17M
-43.85%-1.41M
-279.35%-2.07M
14.36%-976.74K
20.76%-546.84K
-162.51%-1.14M
-32.59%-690.11K
---434.48K
---520.48K
Net income from continuing operations
27.40%-1.43M
49.56%-1.09M
7.50%-1.97M
-116.82%-2.16M
-107.93%-2.13M
2.93%-995.39K
27.01%-1.03M
-93.76%-1.03M
---1.41M
---529.20K
Operating gains losses
-5.37%168.49K
-17.83%166.87K
-11.80%178.06K
6.34%203.09K
19.66%201.88K
18.51%190.98K
10.62%168.72K
15.11%161.16K
--152.53K
--140.01K
Other non-cash items
49.76%-127.13K
-388.32%-190.54K
-126.66%-253.05K
-52.58%66.09K
612.01%949.01K
-17.69%139.37K
-132.60%-185.35K
4138.15%169.31K
--568.54K
--4.00K
Change in working capital
-69.98%110.89K
35.22%-171.30K
1859.02%369.33K
-390.41%-264.42K
105.04%18.85K
1789.38%91.05K
-249.10%-374.07K
103.56%4.82K
--250.88K
---135.28K
-Change in receivables
-207.86%-120.43K
135.36%41.34K
155.28%111.65K
-305.82%-116.91K
48.75%-201.97K
245.66%56.80K
-826.12%-394.12K
67.36%-39.00K
---42.56K
---119.49K
-Change in inventory
----
----
----
----
----
----
-50.41%80.41K
50.41%-80.41K
--162.15K
---162.15K
-Change in payables and accrued expense
-49.93%129.03K
-44.15%-212.63K
16.69%257.68K
-530.71%-147.51K
465.88%220.82K
-72.43%34.25K
-145.97%-60.35K
-15.13%124.22K
--131.28K
--146.36K
-Change in other current liabilities
--102.29K
----
----
----
----
----
----
----
----
----
Cash from non-recurring investing activities
Cash from operating activities
-11.35%-1.56M
43.81%-1.17M
-43.85%-1.41M
-279.35%-2.07M
14.36%-976.74K
20.76%-546.84K
-162.51%-1.14M
-32.59%-690.11K
---434.48K
---520.48K
Investing cash flow
Net cash from continuing investing activities
2123.37%915.29K
5213.60%910.11K
-19.65%41.17K
-95.94%17.13K
-90.99%51.23K
2956.28%422.07K
358.00%568.54K
-90.21%13.81K
--124.14K
--141.02K
Capital expenditures
2123.37%915.29K
5213.60%910.11K
-20.41%41.17K
-95.94%17.13K
-90.90%51.72K
2956.28%422.07K
358.00%568.54K
-90.21%13.81K
--124.14K
--141.02K
Net cash flow from disposal of fixed assets
1894.52%821.08K
5213.60%910.11K
-19.65%41.17K
-95.94%17.13K
-90.99%51.23K
2956.28%422.07K
442.67%568.54K
-90.13%13.81K
--104.77K
--139.96K
Net cash flow from intangible asset transactions
--94.21K
----
----
----
--0.00
----
-100.00%0.00
-100.00%0.00
--19.37K
--1.06K
Net cash flow from investment products
--330.97K
----
----
----
-100.00%0.00
100.00%0.00
197.34%241.31K
---241.31K
---247.90K
--0.00
Net cash flow from other investing activities
229.87%3.60M
82.04%-977.68K
---2.77M
---5.44M
----
----
----
----
----
----
Cash from non-current investing activities
Net cash flow from investing activities
207.19%3.01M
65.42%-1.89M
-5388.74%-2.81M
-1193.60%-5.46M
90.99%-51.23K
-65.44%-422.07K
-52.82%-568.54K
-80.91%-255.12K
---372.03K
---141.02K
Financing cash flow
Cash flow from continuous financing activities
-556.65%-24.84K
-100.18%-19.74K
-99.52%5.44K
28672.96%10.96M
246.72%1.13M
-100.97%-38.36K
-67.36%326.56K
301.10%3.96M
--1.00M
--988.41K
Net cash flow from debt Issuance/repayment
-556.65%-24.84K
94.29%-19.74K
106.02%5.44K
-801.58%-345.87K
-127.68%-90.40K
-8.16%-38.36K
-34.77%326.56K
-103.59%-35.47K
--500.63K
--988.41K
Net cash flow from common stock issuance/repurchase
----
-100.00%0.00
-100.00%0.00
--11.31M
--1.22M
-100.00%0.00
-100.00%0.00
--2.00M
--500.00K
--0.00
Net cash flow from other financing activities
----
----
----
----
--0.00
-100.00%0.00
--0.00
--2.00M
--0.00
--0.00
Net cash from non-recurrent financing activities
Net cash from financing activities
-556.65%-24.84K
-100.18%-19.74K
-99.52%5.44K
28672.96%10.96M
246.72%1.13M
-100.97%-38.36K
-67.36%326.56K
301.10%3.96M
--1.00M
--988.41K
Net cash flow
Beginning cash balance
-69.12%3.22M
469.41%9.00M
601.86%10.44M
-37.13%1.58M
-61.83%1.49M
183.84%2.51M
465.60%3.90M
138.66%885.27K
--688.82K
--370.94K
Current period cash flow changes
134.98%1.47M
-187.87%-3.00M
-4652.45%-4.21M
433.00%3.42M
106.69%92.56K
-134.07%-1.03M
-804.07%-1.38M
847.13%3.01M
--196.46K
--317.87K
Effect of exchange rate changes
2658.77%49.03K
727.35%72.11K
83.65%-1.92K
37.30%-11.49K
-1742.61%-11.72K
-112.85%-18.33K
-127.19%-636.00
4.66%-8.61K
--2.34K
---9.03K
Ending cash balance
-24.54%4.70M
20.00%5.99M
294.01%6.22M
235.87%4.99M
-37.13%1.58M
-61.83%1.49M
183.84%2.51M
465.60%3.90M
--885.27K
--688.82K
Free cash flow
-71.47%-2.48M
0.75%-2.08M
-40.62%-1.45M
-115.87%-2.09M
39.82%-1.03M
-37.65%-968.91K
-205.96%-1.71M
-6.41%-703.92K
---558.62K
---661.50K
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
